Psychometric evaluation of health-related quality of life measures in women after different types of delivery

Jansen, A.J. Gerard; Essink‐Bot, Marie‐Louise; Duvekot, Johannes J.; Rhenen, D.J. van

doi:10.1016/j.jpsychores.2007.06.003

Cited by 69 publications

(109 citation statements)

References 30 publications

Supporting

Mentioning

105

Contrasting

Order By: Relevance

“…111,112,115,116,119 Four studies had relatively small patient numbers (fewer than 250 total participants). [116][117][118]120 Only the Petrou et al 119 and the Bijlenga et al 111,112 studies utilised the EQ-5D questionnaire. Petrou et al used the EQ-5D in a general pregnancy population, with two groups of patients classified by spontaneous or non-spontaneous birth.…”

Section: Hrqol Evidence From Additional Systematic Searchesmentioning

confidence: 99%

“…Seven studies reported SF-36 data. [111][112][113][114][115][116][117] One study reported SF-12 data.…”

Section: Derivation Of Utility Estimates From Hrqolmentioning

confidence: 99%

“…A close value, 0.89, was obtained by mapping SF-12 values to EQ-5D utility scores at 6 months post partum from Ngai et al, 118 a Hong Kong study (see Table 37). Likewise, the Dutch study, by Jansen et al, 116 produced a mean utility score of 0.89 when mapped from SF-36 for women at 6 weeks post partum. The mapped values appear to support that women have an almost full recovery at 6 weeks post partum, and a full recovery to pre-pregnancy HRQoL by 6 months.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis

Frampton

Jones

Rose

et al. 2016

Health Technol Assess

View full text Add to dashboard Cite

growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technol Assess 2016;20(87).Health Technology Assessment is indexed and abstracted in Index Medicus/MEDLINE, Excerpta Medica/EMBASE, Science Citation Index Expanded (SciSearch ® ) and Current Contents ® / Clinical Medicine. This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/). Health Technology Assessment NICE TAR and DAREditorial contact: nihredit@southampton.ac.ukThe full HTA archive is freely available to view online at www.journalslibrary.nihr.ac.uk/hta. Print-on-demand copies can be purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk Criteria for inclusion in the Health Technology Assessment journalReports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. HTA programmeThe HTA programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform National Institute for Health and Care Excellence (NICE) guidance. HTA research is also an important source of evidence for National Screening Committee (NSC) policy decisions.For more information about the HTA programme please visit the website: http://www.nets.nihr.ac.uk/programmes/hta This reportThe research reported in this issue of the journal was commissioned and funded by the HTA programme on behalf of NICE as project number 14/69/05. The protocol was agreed in March 2015. The assessment report began editorial review in September 2015 and was accepted for publication in June 2016. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.This report presents independent research funded by the National Institute for Health Research (NIHR). The ...

show abstract

Section: Hrqol Evidence From Additional Systematic Searchesmentioning

confidence: 99%

“…Seven studies reported SF-36 data. [111][112][113][114][115][116][117] One study reported SF-12 data.…”

Section: Derivation Of Utility Estimates From Hrqolmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis

Frampton

Jones

Rose

et al. 2016

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…The obtainable score within each subscale ranges from four (absence of fatigue) to 20 (maximum fatigue). The MFI has high feasibility, reliability, and validity in chronically anemic and postpartum women [21]. The EPDS detects symptoms of depression in puerperal women during the previous 7 days [22].…”

Section: Endpointsmentioning

confidence: 99%

Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage

Holm

Thomsen

Langhoff‐Roos

2018

The Journal of Maternal-Fetal & Neonatal Medicine

View full text Add to dashboard Cite

Background and objectives: To explore if intravenous iron isomaltoside (Monofer V R ) leads to a better relief of fatigue than current treatment practice with oral iron in women suffering from severe fatigue after postpartum hemorrhage. Materials and methods: This is a subanalysis of a single-center, open-label, randomized controlled trial conducted in women suffering from postpartum hemorrhage. Participants were randomized 1:1 to 1200 mg iron isomaltoside or current treatment practice with oral iron. We measured fatigue by the Multidimensional Fatigue Inventory (MFI) and Edinburgh Postnatal Depression Scale, and determined hematological parameters. The subanalysis includes all participants with a high fatigue score (MFI physical fatigue score >15) at inclusion. The primary endpoint was aggregated change in physical fatigue score from inclusion to 12 weeks postpartum with a predefined minimum clinically relevant difference of 1.8. The trial is registered at ClinicalTrials.gov (identifier: NCT01628770). Results: A total of 85 women had a high fatigue score at inclusion. The aggregated change in physical fatigue score was À2.3 (confidence interval 95%: À3.3; À1.3) (p < .0001) in favor of iron isomaltoside. Significant differences in other fatigue and depression scores and hematological parameters were observed and all in favor of iron isomaltoside. There were no differences in side effects between the groups. Conclusions: In women suffering from severe fatigue after postpartum hemorrhage, a single dose of iron isomaltoside is associated with a statistically significant and clinically relevant reduction in aggregated physical fatigue within 12 weeks after delivery, when compared to current treatment practice with oral iron and with a similar safety profile.

show abstract

“…Although most of these changes return back to the normal state, some of them related to mothers` health may remain for a long time. Some of the associated complications may be so severe or elongated that they bring mothers to disability or even death after delivery [3]. Based on the reports of world health organization (WHO), 1600 women per day pass away because of consequences of delivery and pregnancy.…”

Section: Introductionmentioning

confidence: 99%

The effect of education based on health belief model on postpartum care in pregnant women

et al. 2018

View full text Add to dashboard Cite

The integrated postpartum care is the most important factor in the prevention and reduction of delivery complications. Despite the free services for pregnant women, mothers do not show their interest to use them as appropriate. Therefore, this research was carried out to determine the effect of training pregnant women based on health belief model (HBM) on increasing the use of postpartum health care. This research was an empirical study (before-after study) conducted on 90 pregnant women referring to healthcare centers of Hamadan. The participants were randomly divided into two intervention (n=45) and control (n=45) groups. The educational intervention in this research was based on HBM performed as lecturing and question/answering in four 1-hour sessions and presenting educational content as leaflet. A researcher-made questionnaire was used in 3 stages of before intervention, and immediately after intervention, and 2 months after delivery to collect data. The comparison of the two groups showed that the mean of knowledge and constructs of HBM (including perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy) as well as behavior of mothers after training had a significant increase in the intervention group compared to the control group. According to the obtained results, designing and implementing training programs based on health belief model can help promote mothers` behavior in postpartum care. Keywords: Education, Health Services, Maternal, Postpartum Care Journal of Research & HealthSocial Development & Health Promotion Research Center Vol. 8, No. 4, Jul & Aug 2018 Pages: 382-391 DOI: 10.29252/jrh.8.4.382 Original Article

show abstract

Psychometric evaluation of health-related quality of life measures in women after different types of delivery

Cited by 69 publications

References 30 publications

Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis

Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis

Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage

The effect of education based on health belief model on postpartum care in pregnant women

Contact Info

Product

Resources

About